Background: There is a lack of contemporary data on cardiogenic shock (CS) in‐hospital mortality trends. Methods and Results: Patients with CS admitted January 1, 2004 to December 31, 2018, were identified from the US National Inpatient Sample. We reported the crude and adjusted trends of in‐hospital mortality among the overall population and selected subgroups. Among a total of 563 949 644 hospitalizations during the period from January 1, 2004, to December 30, 2018, 1 254 358 (0.2%) were attributed to CS. There has been a steady increase in hospitalizations attributed to CS from 122 per 100 000 hospitalizations in 2004 to 408 per 100 000 hospitalizations in 2018 ( Ptrend <0.001). This was associated with a steady decline in the adjusted trends of in‐hospital mortality during the study period in the overall population (from 49% in 2004 to 37% in 2018; Ptrend <0.001), among patients with acute myocardial infarction CS (from 43% in 2004 to 34% in 2018; Ptrend <0.001), and among patients with non–acute myocardial infarction CS (from 52% in 2004 to 37% in 2018; Ptrend <0.001). Consistent trends of reduced mortality were seen among women, men, different racial/ethnic groups, different US regions, and different hospital sizes, regardless of the hospital teaching status. Conclusions: Hospitalizations attributed to CS have tripled in the period from January 2004 to December 2018. However, there has been a slow decline in CS in‐hospital mortality during the studied period. Further studies are necessary to determine if the recent adoption of treatment algorithms in treating patients with CS will further impact in‐hospital mortality.
1 November 2018 in International Journal of Cardiology
Background: Numerous studies have shown conflicting results regarding the natural history and outcomes with alcoholic cardiomyopathy (AC).Hypothesis: Determining the trends in hospitalization among patients with AC and associated outcomes will facilitate a better understanding of this disease.Methods: We conducted our analysis on discharge data from the Healthcare Cost and Utilization Project‐Nationwide Inpatient Sample (HCUP‐NIS) from 2002 through 2014. We obtained data from patients aged ≥18 years with diagnosis of “Alcoholic Cardiomyopathy.” Death was defined within the NIS as in‐hospital mortality. By using International Classification of Disease‐9th edition‐Clinical Modification (ICD‐9CM) diagnoses and diagnosis‐related groups different comorbidities were identified.Results: We studied a total of 45 365 admissions among patients with AC. The absolute number of admissions decreased from 2002 to 2014 (3866‐2834 admissions). In‐hospital mortality was variable throughout study duration without a clinically relevant trend (Mean 4.5%, range 3.6%‐5.6%). The patients were mostly male (87%) and Caucasian (50.5%). Commonest age groups involved were 45‐59 years (46.7%) followed by 60‐74 years (29.2%). Trends in associated comorbidities such as smoking, drug abuse, depression, and hypertension increased over the same time period. Among all admissions, almost half were for cardiovascular etiologies (48.9%) and heart failure (≈24%) was the commonest reason for hospital admission.Conclusion: While the overall admissions among patients with AC decreased over time, the proportion of patients with high‐risk characteristics such as smoking, depression, and drug abuse increased. Patients aged 45 and older were largely affected and cardiovascular etiologies predominated among causes for admission.
Background: Left ventricular thrombosis (LVT) is a well‐known complication of acute myocardial infarction, most commonly seen in anterior wall ST‐segment elevation myocardial infarction (STEMI). It is associated with systemic thromboembolism.Hypothesis: Our aim was to evaluate the impact of LVT on in‐hospital mortality, thromboembolism, and bleeding in patients with anterior STEMI.Methods: Data was collected from the Nationwide Inpatient Sample where patients with a primary diagnosis of “Anterior STEMI” [ICD9‐CM code 410.1] were included. Comparisons were made between patients with LVT [ICD9‐CM code 429.79] vs those without using propensity score matching (PSM).Results: From 2002 to 2014, there were 157 891 cases of anterior STEMI. Among these, 649 (0.4%) had LVT. Post‐PSM, there was no difference in in‐hospital mortality between the groups with LVT and without (7.3% vs 8.6%). Thromboembolic event rate was higher with LVT compared to those without LVT (7.3% vs 2.1%). There was no difference in bleeding events between patients with LVT and those without (2.9% vs 3.2%). The baseline average length of stay in the group with LVT was longer than the group without LVT (7.9 ± 6.7 days vs 5.1 ± 6.0 days). The average hospitalization‐related costs were also significantly higher among patients with LVT compared to those without (95 598 USD vs 66 641 USD per stay) at baseline.Conclusion: Among patients hospitalized with anterior STEMI, presence of LVT is associated with increased thromboembolic events, average length of hospital stay and average cost of hospitalization. However, it is not associated with increased in‐hospital mortality or bleeding events.